Creutzfeld-Jakob disease: Australian surveillance update to 31 December 2004
DOI:
https://doi.org/10.33321/cdi.2005.29.25Keywords:
Creutzfeldt-Jakob disease, disease surveillance, transmissible spongiform encephalopathyAbstract
The Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR) was established in October 1993 after the identification of probable iatrogenic CJD in recipients of human pituitary hormones. Since this time and with the recommendations of the Allars inquiry into CJD in Australia,1 the registry has performed surveillance of CJD in Australia with retrospective ascertainment to 1970 and ongoing prospective ascertainment of all human prion diseases or transmissible spongiform encephalopathies (TSEs). Prion diseases include CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia and Kuru. This brief summary presents the epidemiological findings of the ANCJDR based on data from 1970 to 31 December, 2004. Commun Dis Intell 2005;29:269–271.
Downloads
References
Allars M. Inquiry into the use of pituitary derived hormones in Australia and Creutzfeldt-Jakob disease. Report – June 1994. Australian Government Publishing Service, 1994.
Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005;64:1586–1591.
Collins S, Boyd A, Lee JS, Lewis V, Fletcher A, McLean CA, et al. Creutzfeldt-Jakob disease in Australia 1970–1999 Neurology 2002;59:1365–1371.
Downloads
Published
How to Cite
License
Copyright (c) 2005 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
